Herpes simplex virus-2 infection is characterized by frequent episodic shedding in the genital tract. Expansion in HSV-2 viral load early during episodes is extremely rapid. However, the virus invariably peaks within 18 hours and is eliminated nearly as quickly. A critical feature of HSV-2 shedding episodes is their heterogeneity. Some 
| INTRODUC TI ON
Herpes simplex virus-2 (HSV-2) is an important human pathogen that is the leading cause of recurrent genital ulcers, a risk factor for enhanced HIV acquisition, and the occasional cause of severe disseminated disease. 1 Partially effective antiviral therapies licensed over 2 decades ago limit the extent of recurrent ulcers, lower the clinical recurrence rate and genital shedding rate when given prophylactically, [2] [3] [4] and diminish the risk of sexual transmission between infected persons when taken on a daily basis. 5 However, the quest for licensure of an effective prophylactic vaccine has been expensive and thus far unsuccessful. [6] [7] [8] [9] Recent development of therapeutic vaccines that appear to be nearly as effective as licensed antiviral therapies has energized the field. 10, 11 Moreover, new technologies applied in conjunction with creative study protocols have shed considerable light on the nature of the tissue-resident T cell response to reactivations during chronic HSV-2. [12] [13] [14] Nevertheless, it is clear that optimizing the development and dosing of future vaccines will require a deeper understanding of the tissue-specific immune response that underlies containment of HSV-2. This fact has allowed completion of perhaps the most comprehensive studies to date of interactions between the virus and tissueresident host immune cells for a human viral pathogen. Our group has used the kinetics of viral shedding as a probe to better understand the timing and intensity of the endogenous immune response to HSV-2. 2, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] We developed protocols employing highly frequent and spatially granular sampling for local viral load. These studies demonstrated that the local immune response against HSV-2 exerts significant pressure within 6-18 hours of viral detection. 26, 27 However, HSV-2 reactivation within a single host follows a unique pattern, in which some shedding episodes are extremely rapidly contained within hours, whereas others persist for more than a week.
This observed variability in episode duration suggests that immunologic success fluctuates spatially and temporally within an infected individual. 16, 19 Because genital lesions and healing tissue can be safely and repeatedly biopsied, HSV-2 has proven to be an ideal platform for assessing the potential role of specific immunological factors in dictating episode heterogeneity. Detailed, serial analysis of infected human tissue has revealed a role for tissue resident CD8+ T cells (T RM ) in limiting the duration of HSV-2 episodes. 12, 13, 28 T RM are a subset of T-cells which remain lodged within solid tissues without recirculating in blood and provide in situ immunosurveillance at prior sites of infection. [29] [30] [31] [32] [33] In human tissues, T RM can be differentiated from circulating effector memory T cells (T EM ) by their cell surface markers, transcriptional profile, 34 and micro-localization within tissue. [12] [13] [14] 35 Based on its replication in peripheral tissues and broad cellular and animal tropism, HSV-2 has emerged as a crucial tool for immunologists who develop murine systems to characterize the precise functions of T RM . 33, [36] [37] [38] Recent evidence from experiments in mice highlights a critical role of T RM in determining the extent of pathogen spread and resultant tissue damage prior to recognition and clearance. [39] [40] [41] T RM persist in tissue following pathogen clearance, [42] [43] [44] actively patrol between target cells, 45, 46 express dendritic arms to interface with a large number of possibly infected cells, 45, 46 proliferate locally, 40, 47 express a rapid alarm signal upon contact with cognate antigen, 44, 48 and can rapidly and cooperatively kill infected cells via T cell receptor-mediated granzyme release. 49 In human studies, T RM express gene signatures of T-cell activation months after pathogen elimination. 14, 35 The multi-faceted immune-surveillance functionality of T RM raises the exciting possibility that these cells may be harnessed to provide rapid protection of barrier and non-lymphoid tissues following vaccination or immunotherapies.
Many questions regarding T RM activities during and after elimination of virally infected cells can only be answered with elegant transgenic murine systems in which tissue resident T cells can be generated, labeled, expanded, and observed longitudinally in situ. 40 While many of these mechanisms are likely to be fundamental to HSV-2 control in humans, it is currently extremely challenging to directly confirm their clinical relevance. A major priority in the field is to identify links between murine and human experimental systems, and to ultimately establish mechanistic correlates of vaccine protection following therapeutic vaccination. 50 Mathematical models are a useful technique for filling in some of these persistent gaps. Models allow the synthesis of available viral kinetics data with multiple qualitative features of the T RM response observed in humans. More detailed quantitative observations of T RM proliferation, killing, and movement observed in mice can be imported into model equations to assess whether they improve or damage model fit to observed human viral load data. Differential equations are in fact essential to properly account for the non-linearity of pathogen-host interactions, as well as the stochastic factors inherent to early reactivation. When applied optimally, models are employed in an iterative fashion in close conjunction with experimental work. They are designed to help explain observed experimental data, but also to generate hypotheses which can be tested with subsequent experimental protocols.
In this review, we describe our research group's efforts to use mathematical models as a method to infer the dynamics underling T RM control of HSV-2. Our modeling approach has generated numerous predictions, many of which have been experimentally verified in recent animal model and human studies. These predictions include the concepts that (i) immunologic control within the dorsal root ganglia is leaky, which allows persistent drip of infectious HSV-2 from neuronal cell bodies ganglia into the genital tract via neuronal connections 17 ; (ii) T RM density at the precise site of reactivation dictates the extent of infection spread prior to local HSV-2 elimination 16, 20 ;
(iii) rapid local expansion of the T RM response leads to contraction in viral loads within 12-24 hours of mucosal reactivation 15, 19 ; (iv) heterogeneous but highly organized T RM clustering is a feature of chronic infection; and (v) T RM pressure must be considered in order to accurately simulate clinical trials of small molecular antiviral agents. 20, 51 Our modeling approach also highlights key knowledge gaps in the field as well as challenges in studying mechanisms of viral pathogen containment in tissue. Because elimination of virally infected cells is never directly observed in real time in humans, the relative contributions of different cellular subsets including CD4+
T-cells, antigen presenting cells, and natural killer cells are currently impossible to discern. This fundamental problem is exacerbated by the extremely rapid timeframes and microscopic distances over which infected cells are eliminated. While animal models allow a more detailed mechanistic understanding of T RM behavior, pathogen containment is still rarely observed directly. Moreover, for various reasons, many experimental models do not accurately recapitulate all aspects of human infection conditions. Mathematical models are essential to capture the non-linear spatiotemporal features of T RMpathogen interface. Yet even the most complex models dramatically oversimplify the infection micro-environment and invariably do not include key features of the host response. For these reasons, we suggest that continued progress in the field requires tight synergy between human studies, animal models, and theoretical modeling approaches. 
| H S V-PATHOG ENE S IS

| Genital shedding as a probe of virus-host interactions
Over the last 20 years, over a 1000 study participants have participated in research studies at the University of Washington which have allowed detailed characterization of genital HSV-2 shedding kinetics. Typically study participants perform longitudinal self-genital swabs at home and return these samples to the clinic. This method is as reliable, and more efficient, than clinician sampling. 60 Swabs are subsequently processed for quantitative HSV-2 PCR which provides a measure of the burden of viral replication.
Individual studies vary according to study population, intervention, sampling location, and sampling frequencies. Collectively, these studies have allowed us to precisely define the kinetic patterns of HSV-2 shedding in the genital tract. Genital shedding rate (percentage of swabs with detectable HSV-2 DNA) and lesion rate are the most relevant outcomes for clinical trials and vary across infected persons. 61, 62 To better understand the basic pathogenesis of infection, we developed more detailed quantitative methods to characterize viral expansion and clearance. 18, 19, 21 Our approach provides a rough estimation of the timing of the immune response against the virus over various temporal and spatial scales.
| Episodic genital HSV-2 shedding implies local immunologic clearance of episodes
Our most comprehensive analysis of HSV-2 shedding kinetics to date was from 531 immunocompetent study participants who donated 30-60 daily swabs for analysis. Several critical patterns from prior studies were confirmed. First, HSV-2 shedding is episodic with an annualized episode rate of 17.2, signifying a high frequency of HSV-2 reactivation from the ganglia leading to replication in the genital mucosa. 21 Second, in a majority of immunocompetent persons, each episode terminates, which suggests that despite the high frequency of recurrent battles in the genital mucosa, the immune system ultimately wins each battle in a majority of immunocompetent persons. However, it can be argued that the virus wins the war, given the high overall rate of shedding (~12%-18% of swabs positive for HSV-2 depending on the study) that facilitates efficient transmission and development of multiple recurrences per year in many infected people. . 21 A higher proportion of episodes (~40%) were moderate in severity, peaking between 10 000 and 1000 000 HSV DNA copies, often lasting 1-3 days. We consider the immune response during these moderate episodes to be partially effective: virus is usually eliminated prior to reaching a high enough burden of killed epithelial cells to cause symptomatic lesions. On the other hand, the high overall frequency, relatively prolonged shedding phase, and higher viral loads of these episodes likely contribute to highly efficient transmissibility of the virus between sexual partners. 55 The critical role of the local immune response in episode heterogeneity was further confirmed in studies of immunocompetent participants who performed self-sampling every 6 hours for HSV-2 DNA. In these studies, over 50% of episodes peaked at only 100 to 10,000 copies, lasted fewer than 12 hours, and were asymptomatic. 27 These results demonstrate that local immune cells are often capable of extremely rapid recognition and elimination of virally infected cells.
The most extraordinary feature of the extreme variability in HSV-2 shedding episode severity is that this variability is observed across study participants, but also within the same study participants over the short time window of a couple weeks ( Figure 1A ). It Indeed, HSV-2 infection is characterized by "low" and "high" shedders, the latter of whom is most likely to experience frequent and bothersome disease manifestations. 23, 63 In the case of HSV-2, similarly important comparisons must also be made within a singleinfected person.
| Early potent activity of the local anti-HSV-2 immune response regardless of episode severity
We used our frequency histograms to describe variability in the first detected value of HSV DNA genomic copies per episode and identified F I G U R E 1 Herpes simplex virus-2 genital shedding episodes are notable for extraordinary heterogeneity in terms of peak viral load and duration. (A) Individual shedding trajectories from 3 study participants who self-sampled every 6 hours over 60 days. Arrows indicate high (1), medium (2) , and low (3) copy episodes. Data is from Refs. [17] and [27] . (B & C) Data from 1020 shedding episodes in 531 study participants (figure adapted from Refs. [19] and [21] ) who performed daily self-sampling of the anogenital region for 30-60 days. Colored bars are actual data and black bars are from optimized simulations of the mathematical model in Figure 5 . (B) Frequency histogram of observed episode peak viral load. (C) Frequency histogram of observed episode duration. Interval censoring means that episodes which were not observed completely (ie, initiated before sampling began or ended after sampling terminated) are excluded. It is notable that the cohort described in B and C is likely overestimating median peak viral load and duration because brief episodes lasting less than 12 hours which compromise ~50% of observed episodes are missed with daily sampling a wide range of viral loads (10 2 -10 8 HSV DNA genomic copies). 19, 21 This heterogeneity reflects in part the age of the episode at detection (which might vary from 0 to 24 hours), but also the variability in severity of the episode itself. The fact that HSV-2 viral loads can reach 10 8 genomic copies in the first 24 hours of an episode reflects extraordinarily high rates of replication and spread and is a signal that the tissue resident immune response must be poised, spatially and functionally, to achieve immediate efficacy upon re-exposure to HSV-2.
Remarkably nearly all of the episodes sampled every 6 hours in our database peak and enter a viral clearance phase within 18 hours of viral detection, implying very quick recognition of, and response to, reactivating infection. 27 Accordingly, local and systemic sequelae related to HSV-2 reactivation during chronic infection are less severe relative to those occurring during primary HSV-2 infection. Individual shedding episodes are notable for complex HSV-2 dynamics, which likely reflect viral-host interactions. We designed protocols in which participants collected samples every 2 hours during symptomatic genital HSV-2 lesions. 19 A surprising finding from these studies was that shedding episodes lasting for more than 2 days nearly always consisted of multiple viral load peaks (Figure 2A ).
Specifically, episodes typically exhibit a very rapid early expansion phase: the first peak typically occurs within 6-18 hours of viral detection. This is followed by a period of non-monotonic viral contraction, and then another period of expansion to a second peak, usually at a lower viral load. To ensure that this observation is biologically valid
and not due to variability in sampling or laboratory methods, we performed a study in which participants self-sampled every 5 minutes for 4 hours: extremely stable viral loads were noted implying that fluctuating levels over 2-hour intervals reflect the true biology of the disease. 19 Thus, the observed rebound in viral load during shedding episodes must ultimately be explained on immunologic grounds. Figure 2B ). To account for the fact that shedding may also be similarly spatially dispersed, a landmark study was performed at the University of Washington in which several study participants were sequentially sampled at 23 separate micro-environments on a daily basis for 1 month ( Figure 2C ). 67 A key result was that during high-copy shedding episodes, the virus is often shed concurrently at multiple locations across the genital tract, with heterogeneous levels noted across time and space. Brief, more rapidly controlled episodes were often contained at lower viral loads within single mucosal locations but appeared to initiate in multiple non-adjacent regions over longer periods of sampling. The critical message for considering immunity is that there is also likely to be extraordinary heterogeneity across genital mucosa and skin in terms of the intensity and effectiveness of the cellular immune response. Moreover, concurrent viral-host interactions are likely to be occurring at dozens of micro-anatomic sites during large reactivations. When developing mathematical models of this system, it is critical to specify whether a single battlefield, or the entire, war, are being described.
| TISSUE-RE S IDENT T CELL S DURING H S V-2 INFEC TI ON
Tissue-resident T cells are a subset of T cells that are defined by their permanent establishment in tissues throughout the body, without recirculation in blood. 29, 33 This concept of permanent tissue lodgement has been defined using parabiosis models in mice. 68 While the study of human T RM does not benefit from such elegant experimental systems, phenotypic markers as well as defined tissue localization has allowed for parallel study of human T RM in various mucosal tissues. Specifically, human T RM can be defined with varying degrees of specificity according to cell-surface markers, transcriptional profiling, and lack of observed recirculation. 
| Characterization of tissue residence in T-cells
Many subsets of T cells achieve tissue residence, including both
CD4+ T cells and CD8+ T cells. Tissue resident CD4+ T cells may
be further sub-classified according to subsets including T-regulatory cells. 77, 79, 80 For the purpose of this review, we focus on tissueresident CD8+ T cells (T RM ) because these cells localize precisely to the site of HSV-2 replication and have known potent antiviral effects. 13, 14, 28 This is not meant to imply that tissue-resident CD4+
T-cells do not play a vital role in elimination of infected cells, but rather to reflect that quantitative data describing the interactions between CD4+ and CD8+ tissue-resident T-cells during a local immune response is currently too limited for inclusion in mathematical models.
The most fundamental feature of T RM is their sessile phenotype.
The rarity of T RM recirculation was established in parabiosis studies, in which the circulatory systems of 2 mice are joined to allow even mixing of circulating T cells: tellingly, T cells in peripheral tissues equilibrate to a much lesser extent due to their lack of recirculation. 68 Labeling experiments demonstrate that persistence of this population does not depend on contribution from circulating T cells. 40, 47 In humans, donor tissue-resident T cells with tissueresident markers were noted in a biopsy following a facial transplan- 
| Mechanisms of rapid pathogen clearance mediated by tissue-resident T-cells in genital tissue
By virtue of its natural replication in external anatomic sites such as skin and mucosa, HSV-2 has proven to be an ideal model pathogen for interrogating the potent and varied antiviral mechanisms of T RM . 39, 40, 82, 83 Mouse models have been essential for delineating these mechanisms, many of which can only be measured indirectly in humans. Mathematical models can assist by linking mechanisms observed in mice with the available human data, thereby forming the third, in silico arm of the trifecta of approaches used to study mechanisms of immune control of HSV-2.
The most important HSV-2 clearance mechanisms studied to date include in situ proliferation, rapid and cooperative TCRmediated killing, and generation of a tissue-wide alarm response that in many ways resembles an innate response. Two recent papers, one using HSV challenge, utilized elegant labeling and intravital imaging techniques to demonstrate that the massive local surge in T RM during the first 3 days of pathogen elimination is almost entirely due to local T RM proliferation ( Figure 3A ), rather than off-site generation of new cells capable of migrating to tissue sites. 40, 47 This timeframe is consistent with the observed interval to rapid viral disappearance from local sites of infection during chronic human HSV-2. Trafficking of effector memory cells to the inflamed site trails local T RM proliferation and occurs at least 4 days after antigen presentation. 40, 47 The in vivo killing rate of HSV-2 infected cells by T RM is unknown in humans because the relative contribution of other features of the local immune response such as antibody-dependent cytotoxicity, neutralizing antibodies, natural killer cells, and other innate cells cannot be directly measured. Moreover, the indirect killing rate afforded by bystander T RM is also likely to be important but cannot be directly quantified. 84 by amplifying the cytokine response despite lack of specificity of the TCR for an HSV-2 epitope. These mechanisms are likely to underlie the rapidity of the T RM response and may explain how a rapidly expanding virus like HSV-2 can be contained despite a low initial precursor frequency of pathogen-specific T RM at the site of reactivation and shedding. 13, 16, 19, 26, 27 When developing mathematical models of chronic, established 
| Immunosurveillance mechanisms of tissueresident T-cells in genital tissue
The vast majority of a T RM 's lifespan will be spent in waiting, rather than in the heat of battle. However, the transcriptional profiles of T RM do not suggest a fully quiescent state. In human genital biopsies 33, 83 it is possible that these clusters represent quasi-organelles akin to gastrointestinal-associated lymphoid tissues, or GALT.
Ultimately the number and spacing of T RM in tissue is a key parameter of protection upon HSV re-exposure. In mouse model experiments, there is an inverse relationship between total genital tract T RM density and subsequent peak viral titers upon challenge with HSV-2. 39, 40 Another study identified that a parenteral prime and topical chemokine pull strategy can draw circulating effector memory T cells permanently into tissue residence within the genital mucosa. Interestingly, this strategy is lifesaving for the mice prior to HSV-2 challenge despite similar viral dynamics in the control and experimental groups. 83 In humans, the role of tissue-resident T cells in HSV-2 containment is circumstantial but strongly suggestive.
12,13,16
| Tissue-resident CD4+ and CD8+ T-cells in HSV latently infected ganglia
The idea of true and complete HSV-2 latency within dorsal root ganglia has been largely rejected. Rather, the site of latent HSV-2 infection appears to be a highly dynamic viral immune environment. The traditional criticism of murine HSV-2 models is that the virus does not reactivate spontaneously in these animals. Nevertheless, studies demonstrate that a high proportion of infected neuronal cell bodies in mice contain transcriptionally active HSV. 86, 87 Sessile CD8+ T cells are retained in murine ganglia; interestingly, these cells produce granzyme, which inhibits HSV-2 reactivation without leading to cell body damage. 88 A higher number of these T cells has been shown to decrease the frequency of reactivation in these tissues. 89, 90 Human studies are more limited in their ability to identify mechanisms of T cell immunity in ganglia but are consistent with an active role for these cells. In trigeminal ganglia, HSV-1 specific CD4+
and CD8+ T cells cluster around HSV-2 infected neurons. 73, 91 While similar studies have not been performed for HSV-2 in dorsal root ganglia, T-cell deficiency is associated with a higher episode rate of 
| MATHEMATIC AL MODELING OF VIR AL DYNAMIC S
Viral dynamic modeling is a discipline within applied mathematics which was created out of necessity to account for non-linearities inherent to viral load and immunologic data during infections. These models also differ fundamentally from statistical modeling approaches in that model equations have mechanistic assumptions.
Often, models with competing hypotheses are compared in silico for 
| Challenges and limitations of viral dynamic modeling
The "art" of viral dynamic modeling involves the design of sets of equations that are just complex enough to answer the proposed scientific question given a certain set of available data, but no more so.
Mathematically, models that contain too many equations and free parameters lack analytic solutions. Even in models that use simulation techniques, issues of model and parameter identifiability invariably arise. 93 The most complex models may contain thousands allow models which provide a nearly complete mechanistic interpretation of the experiment: this approach has been used to directly classify the potency of nearly all HIV antiviral agents. 94 Animal models of infection and immune response allow control over key experimental variables. For instance, well-defined murine systems permit immune cell types of interest to be followed at reasonably narrow intervals within multiple organ systems. Many papers have used these systems to estimate key parameters such as CD8+ T-cell proliferation rates, elimination rates of infected cells, and within-tissue trafficking rates. [95] [96] [97] Nevertheless, there are limits to the degree of control that can be exerted within animal systems.
Heterogeneity of infection (even within inbred colonies), limitations
in sampling, and most critically, unmeasured critical driver variables, can limit a model's ability to make predictions. For instance, no standard model seems to reliably describe early SIV dynamics in non-human primates. 98 At the other extreme is the most relevant data, which is obtained directly from human infection. However, the challenges related to this data are substantial. Often, available data for modeling is derived from purely observational studies which were not originally performed with modeling in mind. In this case, the availability of lim- describing the expansion, contraction, and killing rates of the bulk cell-mediated response. 99 Even more sophisticated models that consider concepts such as neutralizing antibody generation and T-cell exhaustion, 100 do so in a speculative and phenomenological fashion, owing to the lack of specific, relevant data for model fitting to these variables. In general, available models are able to compare the global assessment of the total cytolytic response across patients.
The nature of existing data for HSV-2 infection is slowly allowing us to develop more sophisticated models to characterize the antiviral immune response.
| Highlights of viral dynamic and immune modeling for infections other than HSV-2
Despite these limitations, modeling has resulted in foundational conclusions regarding pathogenesis of chronic viral diseases, particularly HIV, and has had a major impact on the development of the most important clinical intervention to date, antiretroviral therapy. The original viral dynamic model was applied to bi-phasic HIV clearance data in 2 seminal papers during antiretroviral therapy. 101, 102 This model is notable for its extreme simplicity and also for its obviously false assumption of no underlying immunologic response. This approach allowed linearization of the model and provided the fundamental insight that during viral load steady state, infected cells are replaced on a nearly daily basis while free viruses are replaced in the serum on a time scale of hours. 103, 104 Given that the viral population size is enormous during untreated infection (~10 11 viruses generated per day) and the error rate of the HIV reverse transcriptase is extremely high, this rapid rate of infected cell turnover guarantees the appearance of, and selection for, drug resistance to monotherapy. Strikingly, this extremely simple model was central to the concept of multi-drug therapy to avoid drug resistance.
Subsequent models have provided innumerable insights into very fundamental aspects of infection. Examination of HIV-specific
CD8+ T-cell clone kinetics, as well as patient-specific viral dynamics, 105 has allowed precise specification of the impact of the immune response vs target cell limitation on determining HIV peak viral load and set point. An entire discipline is dedicated to phylodynamic approaches to estimate the average rate of HIV diversification and immune escape. 106 Novel pharmacokinetic and pharmacodynamic models will be vital for dose optimization of each of these new strategies. 109 While the most mature versions of these models currently exist only for HIV infection, they will undoubtedly become highly relevant for HSV-2 infection in the years to come.
| Rationale for mathematical modeling of HSV-2
In 2008, our group elected to develop mathematical models of HSV-2 for 2 broad reasons. First, the necessary conditions for developing reasonable models for HSV-2 shedding were in place. As described above, detailed clinical evaluations of HSV-2 shedding kinetics in humans had been performed, consisting of serial quantitative viral load measurements. Viral kinetics were clearly non-linear in nearly all study participants, suggesting the need for coupled differential equations to fully explain our empirical observations. 21 Moreover, a qualitative understanding of the tissue-resident immune response was also beginning to emerge.
Second, the field was teeming with unanswered, extremely basic questions, some of which we are still attempting to address 
| Unique challenges in developing useful models of HSV-2 infection
There Therefore, despite having the most detailed available datasets of infection site human viral shedding at our disposal, our models can often only provide a very accurate assessment of timing and the overall intensity of the mucosal response rather than experimentally verifiable estimates of particular immune effectors (such as in vivo tissue-resident T-cell expansion and killing rates).
As with HIV models, our approximations of the local immune response oversimplify the true complexity of the dynamic system. We assume all of the local immune response is due to proliferation and killing by local tissue-resident CD8+ T cells (T RM ). We select these cells as a model variable because they reside at the terminus of nerve endings which are at the precise site of HSV-2 replication in the genital epithelium, 13 and because they demonstrate effector functions in the absence of antigen. 14 We do not as of yet explicitly model or account for tissue-resident CD4+ T cells which reside deeper in dermis but likely provide key helper, and direct cytolytic, functions, 33, 58, 115, 116 or regulatory CD4+ T cells which could restrain or limit CD8+ T RM activity. 76, 77 The models ignore any potential dynamic effects of antibodies or innate like cells simply because data is lacking on whether these components of local immunity expand and contract in the presence of viral antigen to the same degree as local CD8+ T cells: it is possible that their antiviral activity is vital but expressed in a constitutive fashion; in this sense, basic model parameters of viral infectivity and replication rate may capture the role of innate immunity.
We also cannot directly model the role of antigen-presenting cells, 117 such as dendritic cells based on lack of sufficient data, though these cells are known to contribute to the innate protection. 115, 118 Instead, the models tend to make the very basic assumption that a certain density of infected cells is necessary to allow local T cell proliferation. This delay in the local proliferative response is necessary for fitting data, 19 and does suggest that given the right data, antigen presentation could be captured with a model. In summary, our models can only generalize the totality of the local immune response at the whole tissue scale due to the lack of adequate contributory data. As described below, our long-term research agenda is to gradually address these limitations.
| APPLIED MODEL S TO H S V-2 S H E D D I N G DATA
Our mathematical model development has proceeded in an itera- 
| Immunologic control of HSV-2 within latently infected ganglia is leaky
The key unknown parameter in our initial model was the release rate of virus from the total body mass of infected dorsal root ganglia, to the genital tract, that would allow approximately bi-weekly detection of shedding episodes. We inferred that most plausible mechanism to explain the high frequency of genital shedding episodes is a nearly constant drip of small numbers of HSV-2 virions (50-100 per day) from the dorsal root ganglia toward the genital tract. 17 Small weekly pulses of virus could also explain the observed episode rate. This prediction does not overturn the latency paradigm of chronic HSV-2 infection, as it still assumes that the vast majority of infected neuronal cell bodies maintain latent HSV-2 at any given point in time. Reactivation from a single neuron is likely adequate to explain our model prediction, which incidentally has remained essentially unchanged with sequentially more complex iterations of the model. 19, 20, 119 Recent work provides supporting evidence to verify the "drip" hypothesis of HSV-2 latency. Unfortunately, it is impossible to longitudinally sample dorsal root ganglia in humans due to inaccessibility of these tissues. However, studies of human trigeminal ganglia following surgical removal revealed varying HSV-1 viral loads on a cell-to-cell basis, suggesting that oral HSV-1 reactivates disproportionately within a tiny fraction of neurons relative to others. 120, 121 Murine models of the ganglia also demonstrate various stages of viral reactivation, with transcripts from all stages of the replication cycle noted. 86 Overall, the state of latency across the entire ganglia seems to be far more spatially and temporally dynamic and heterogeneous than previously predicted. antigen specificities preferentially surround HSV-1 infected cell bodies within the human trigeminal ganglia. 73 Murine models revealed non-cytolytic mechanisms by which these cells may limit reactivation. 88, 122 Further modeling by our group demonstrates that the increased shedding rate and episode rate noted in many patients with late-stage HIV is likely related to more frequent release of HSV-2 from latency: a highly plausible underlying mechanism is poor T cell function within ganglia.
Nevertheless, latency is an extremely complex process. Viral and epigenetic features are likely to be critical, 123 and may vary from person to person. Our model emphasizes a major unmet research need: the role of tissue-resident immunity within latently affected ganglia must be more carefully defined. Enhancing this response in latent and lytic anatomic sites of infection may be critical for future vaccines.
| Heterogeneity in the density of mucosal tissue-resident CD8+ T cells explains the high variability in observed shedding episode severity
We next attempted to understand the mechanism responsible for the extraordinary heterogeneity observed among shedding episodes within infected persons over time. Using a similar model, we developed the prediction that density of T RM at the precise site and time of mucosal HSV-2 reactivation was the prime determinant of peak viral load and shedding duration within that single microenvironment. 16 This prediction is highly relevant because infected genital skin and mucosa is notable for high variability in the density of CD8+
T cells: densely packed clusters of these cells occupy nearly the entire dermal-epidermal region in certain regions following high-titer viral replication. In other areas, which may be less than 0.1 mm away, the ratio of CD8 cells epithelial target cells is much lower, often less than 1:1000 ( Figure 4D ).
After nearly a decade, this model prognostication was formally proven in a murine model system. 39, 40 Using an intravital imaging system, the authors also verified our model's other key prediction that motility cessation and local proliferation of T RM , rather than trafficking of new T cells from blood or lymph, occurs in conjunction with rapid early extinguishment of infection. 40, 47 This result is crucial because in human studies it is daunting task to identify a relevant 1-mm microenvironment in which an HSV-2 reactivation is certain to occur within the timeframe of a clinical study. Indeed, we have formally shown, using a principal components approach, that the timing and location of subsequent HSV-2 shedding episodes is impossible to predict based on prior knowledge of shedding or clinical characteristics, and that HSV-2 shedding data shows features compatible with chaos. 114 While the model used up to this point was simple and helped develop 2 fundamental, testable hypotheses, it had important shortcomings. First, we derived most of the parameters relating to viral replication rate and infectivity, as well as tissue-resident T-cell expansion by fitting a deterministic model to single episodes and then carrying these values over to the stochastic model. 17 This approach required strategic selection of appropriate episodes for analysis: only episodes with monotonic expansion and contraction phases, rather than multiple viral re-expansions shown in Figure 2A , could be modeled. We were therefore ignoring a majority of our observed episodes and fundamentally biasing our parameter estimates. Second, while the model accurately reproduced key quantitative features of the shedding data, it was not trained to provide precise recapitulations of more detailed shedding episode kinetic features, as described above.
Qualitatively, the model was unable to generate prolonged episodes, some of which last longer than 2 weeks, and never generated episodes with multiple erratic peaks of various height. Third, the model did not account for the fact that viral immune battles are clearly occurring in dozens of concurrent spatially discrete locations during more severe HSV-2 reactivations. 67 To achieve a more comprehensive understanding of HSV-2 infection, and in particular to simulate therapy, it was necessary to address these shortcomings.
| Modeling multi-focal reactivations suggests that elimination of HSV-2 replication within single micro-environments occurs extremely rapidly
The goal of our next model was to more accurately recapitulate the entirety of our HSV-2 shedding data set in 531 immunocompetent persons ( Figure 1B, C) . We developed a hive model in which several hundred regions of the genital tract were modeled concurrently over time ( Figure 5A ). These regions were arrayed in an interlocking hexagon formation, with each region representing a 2 mm diameter area of possible HSV-2 replication and spread. 15, 19 Model regions were assumed to be immunologically independent such that T-cells do not traffic between regions or kill across regions. However, free virus from an ulcer in region was allowed to seed adjacent regions. We assumed random neuronal seeding of each region at rates sufficient to produce empirically observed episode rates.
We were ultimately able to fit the updated model to 1020 heterogeneous shedding episodes: when the equations are run over 100 years, the model generates thousands of episodes which match observed variability in episode duration, first observed HSV DNA copy number, peak observed HSV DNA copy number, last observed HSV DNA copy number, and re-expansion frequency. of inter-regional viral seeding, and the addition of inter-regional T-cell trafficking, worsened data fitting despite added complexity. 19 Our updated model was now finely tuned to observed population-level data from 531 study participants and as such generated new hypotheses relevant to tissue-resident immune responses. First, elimination of infected cells within a single microregion was predicted to occur much more rapidly than in our prior models. Even when local viral loads exceeded 100 million HSV DNA copies, all infected cells in the region were usually eliminated within 24 hours. This observation points to the incredible pace of HSV-2 infection but also the extraordinary effectiveness of the endogenous tissue-resident immune response. It also emphasizes that substantial hurdles that must be overcome for a novel therapeutic vaccine to induce an even more effective and rapid system of immunologic defense.
Model simulations also predicted that prolonged episodes occurred entirely due to seeding of cell-free virus from active ulcers into surrounding regions ( Figure 5B,C) . The serpiginous spread of HSV-2 ulcers and multi-peak episodes were also explained by this phenomenon. Spread of virus to multiple regions resulted in high T RM densities in these regions following viral elimination ( Figure 5D ).
| Inter-patient variability of HSV-2 shedding is attributable to differences in specific immune parameters in the model
While our model is an accurate simulator of patient shedding data in a cohort of hundreds of study participants, an insurmountable limitation is its inability to predict future, or even reproduce an individual's past, shedding data. The model's stochastic nature means that in keeping with human HSV-2 shedding data, the timing and trajectories of individual episodes in simulated data are, like the weather, also unpredictable over timeframes exceeding several days. 114 With the aim of providing general predictions about different observed categories of shedders, we performed large multi-parameter sensitivity analyses. These analyses suggest certain value ranges for a small number of model parameters that correlate with higher shedding rates, including high neuronal drip rate of HSV-2, shorter lifespan of T RM in genital mucosa. and low clearance rate of cell-free virus. Globally, these predictions suggest that deficiencies in ganglionic immunity, shortened duration of cytolytic immune memory within the genital mucosa, and lack of mucosal non-neutralizing antibody activity may contribute to more severe disease. 15 We next separately fit the model to cohorts of HIV-infected persons within different strata of CD4+ T cell counts. A first important observation is that HSV-2 shedding was not strictly defined according to strata. Several high shedders were noted in the least immunocompromised hosts (HIV negative and HIV positive with CD4 > 500/uL), while low shedders with clinical AIDS (CD4 < 200/ uL) were also observed. 66 Nevertheless, the population averaged shedding rate was considerably higher in the cohort with AIDS. The model achieving best fit to this cohort data assumed a higher neuronal drip rate of HSV-2, shorter lifespan of tissue-resident T-cells in genital mucosa, and lower clearance rate of free virus relative to the other cohorts, 66 all in keeping with our original sensitivity analysis.
| Tissue-resident T-cells form a highly structured and temporally resilient spatial geographic structure
A recent analysis of emergent model T RM density data from our model suggests that a highly organized spatial structure of T RM is induced by chronic HSV-2 infection (manuscript under review). Specifically, Regions which generated high viral loads transitioned from low to high T RM density as a large amount of local T RM proliferation was required to contain infection. The middle column demonstrates the log10 effective reproductive number (R e ) of each region at the 2 timepoints. This number is inversely correlated with T RM density and denotes the potential for persistent cell-to-cell spread of virus prior to elimination. Green scale regions have R e > 1 (log10 R e > 0) indicating the need for T RM proliferation prior to elimination of all infected cells. Gray scale regions have R e < 1 indicating no need for T RM proliferation prior to very rapid elimination of only a few infected cells. The right column plots the rank of each region according to T RM regional density. The shape of the distribution is stable before and after the episode, in keeping with the stable long-term détente established between HSV-2 and its host, despite dynamic reshuffling of individual region's rank due to localized T RM proliferation events when we rank model regions according to abundance of T RM , we observe an exponential relationship between this rank and local T RM abundance. The morphology and slope of this relationship is nearly constant over timeframes of years despite highly dynamic and unpredictable within-region fluctuations in T RM density during simulated lesions and accordingly, frequent shuffling of individual region ranks ( Figure 5E,F) . This finding may explain why HSV-2 shedding is highly turbulent and chaotic over weeks and months, but much more stable over years and decades. 114 In effect, our model provides a platform for explaining the climate but not for forecasting the weather
To validate the observation of a fixed spatial structure of T RM density in whole infected tissue, we analyzed density of CD8+ T-cells in 8 posthealing, lesional biopsies and identified a very similar spatial structure, albeit across more narrow diameters of tissue and with a steeper exponential slope: the feature driving this finding in the biopsies were clusters of T RM of various size and density scattered across infected tissue ( Figure 4D ).
This amazingly fixed T RM structure implies an underlying dynamic mechanism that is also predicted by the model. The first principle is that the T RM structure is intrinsically linked with the pattern of HSV-2 release from the ganglia during latency. For data fitting purposes, our model must assume that the distribution of HSV-2 release is random across the spatial regions. 19 The stochastic na- is then required to achieve elimination of virally infected cells. This region will therefore be protected for several years going forward, owing to the high density of local T RM . It will also undergo a shift from very low to high rank in our rank abundance curves due to massive local T RM proliferation ( Figure 5E ).
As a comparison, if viral takeoff occurs in a region with slightly higher T RM density, the subsequent peak viral load is only moderate, a lesion may not form locally, and a less substantial amount of T RM proliferation is required to achieve local pathogen elimination.
This region will undergo only a slight increase in rank in our rank abundance curves. Episodes which take off in regions of high T RM density require no local proliferation to achieve viral clearance and these regions do not shift position on the rank abundance curve.
The net effect over time is that the curve does not change its shape, and there is structured heterogeneous T RM density across previously infected tissue ( Figure 5E ).
Functionally, at any point in time a moderate proportion of the genital tract (20%-60%) is fully protected against extensive replication. These episodes are defined mathematically as having an effective reproductive number less than one: due to a threshold density of T RM , virus cannot spread beyond more than a few cells before elimination. 19 This explains why over 50% of observed shedding episodes last fewer than 12 hours and peak at extremely low viral loads. Given the explosiveness of HSV-2 replication and the high sensitivity of our assays, we suspect that many of these episodes reflect HSV-2 replication in a single cell. 16, 17 A lower proportion of regions, roughly 5%-10%, have low enough T RM density to allow a high local effective reproductive number (>5) which in turn puts the region at risk for a high viral load episode with enough killed cells for visual lesion development.
Surprisingly, when we simulate the model with prolonged, potent antiviral treatment, the T RM spatial structure is maintained. In accordance with data from treated patients, the spatial imprint of T RM as a result of chronic infection appears to be extremely resilient. 12 If similar trends are assumed to occur with HSV-2-specific CD4+ T cells, 124 then this may explain why treatment of HSV-2 did not decrease risk of HIV-1 acquisition in 2 clinical trials. 125, 126 Numbers of CD4+ T cells, targets for HIV infection, are increased in the genital tract during chronic HSV-2; this is the proposed mechanism by which chronic HSV-2 infection enhances HIV risk. 12 Our simulations suggest that antiviral therapy would need to be taken for years to diminish this inflammatory footprint of HSV-2. One caveat to this conclusion is that measured clearance rates of CD4+ T cells were obtained in genital skin and it is unknown if similar rates are observed in mucosal tissues. and pharmacodynamics (dose-response curves) of these agents. We then assumed drug concentration-dependent inhibition of HSV-2
replication. These models closely reproduced detailed shedding kinetic data from studies in which participants served as their own controls. We identified that these drugs only eliminate shedding by 50% to 70% because of their short half-life (3.5 hours). We next simulated the phase 2 multi-dose trial of a promising HSV helicase inhibitor that benefits from a much longer half-life (70 hours) relative to acyclovir. 51 The model was again able to fully recapitulate shedding episode kinetics across multiple doses. We made the important practical conclusion that drug potency mea- Past agent-based models, while elegant, were highly theoretical based on the challenges of obtaining sufficiently detailed spatial data for accurate model parameterization and data fitting. 127 However, this is no longer the case for HSV-2. As we have described, detailed studies of T RM proliferation, trafficking, and killing from mouse experiments are now available to inform models, as are experiments tracking HSV-2 cell-to-cell spread. 40, [44] [45] [46] [47] [48] Our group is therefore actively developing complex, but extremely well parameterized, models of the genital ulcer micro-environment. An area of particular interest is the vexing question of how pathogen control is achieved in the 40% of genital tract regions with very low T RM density.
| HSV-2 intra-host phylodynamics
Another area of enormous potential for modeling is intra-host HSV-2 evolution driven by mutation and positive selection. RNA viruses such as HIV and hepatitis C accrue mutations in a predictable and linear fashion, within an infected person who is not being treated. 106, 113, 128 These mutations occur due to the high error rate of viral replication enzymes, as well as occasional recombination events. Certain mutations become fixed in the population as a result of ongoing positive
The pressure exerted by T RM during antiviral therapy remains vital for containment of HSV-2 replication. (A) Simulated episodes on doses of 400 mg acyclovir twice daily (red dots) and placebo (black dots). These simulations recapitulated clinical trial data accurately. For both study arms, a clear inverse relationship between pre-episode T RM density and peak episode viral load is noted. Antiviral therapy blunts the peak viral load at each given T RM density. (B) A single simulated episode shows that HSV-2 expansion (red line, left y-axis) decelerates when drug levels are high (blue line, right y-axis is ratio of drug concentration to EC50 at which inhibition of replication is 50%). Nevertheless, when virus is being cleared, the activity of the drug does not accelerate clearance, owing to the intensity of the cytolytic response (Adapted from Ref. [20] )
selection pressure from the host T cell response. Remarkable population sweeps occur during untreated HIV infection: the dominant strain is replaced approximately once per month. 129 It is currently unknown whether a comparable process exists for HSV-2. The error rate per base pair of HSV DNA polymerase is extremely low relative to HIV reverse transcriptase (though high relative to human DNA polymerase). 130 Moreover, in a majority of infected patients, a continual stream of viral replication is not established as with HIV. Rather, the virus replicates periodically in the genital tract, but is eliminated on each occasion. Finally, the total effective viral population size is many orders of magnitude lower for HSV-2 relative to systemic infections such as HIV, 19, 103 offering fewer opportunities for new mutations to accrue and achieve fixation.
However, HSV-2 has a much larger genome than HIV-1; if measured on a whole-genome basis, the error rate of the viral DNA polymerase is only 5-10 times lower than HIV. 130 In addition, it is quite clear that virus-host interactions are intense and nearly constant in both the peripheral mucosal tissues and the dorsal root ganglia. 13, 14, 73 The latent ganglia serve as a persistent reservoir of Once such data becomes available, modeling will be crucial to identify the frequency of new mutations and population sweeps during the lifetime of an infected person. This information will be highly relevant for vaccine development, to facilitate selection of epitopes that undergo the least variation over time.
| Mathematical modeling of therapeutic vaccines
Mathematical modeling may also be useful in the development of therapeutic vaccines. Designed to lower shedding rate, lesion incidence, and transmissibility in already infected persons, therapeutic vaccines are being pursued more aggressively than prophylactic vaccines at present. Studies for therapeutic vaccines are far less expensive and time consuming than for prophylactic vaccines. Modern study designs allow each participant to serve as their own control, with prevaccine shedding rate used a comparator to postvaccine time points. 131, 132 Licensure of a therapeutic vaccine would likely promote testing of equivalent or similar products in a prophylactic context. 133, 134 Several vaccine products appear promising, based on data from recent trials. The most powerful reduction in shedding was noted for GEN-003, which generated a ~50% reduction in shedding at 3, 6, and 12 months after vaccination. 11 Interestingly, this vaccine generates an increase in HSV-2-specific neutralizing antibodies, non-neutralizing antibodies, and HSV-2 specific T-cells. 10 episode rate, expansion rate, and clearance rate. 15 Mathematical modeling may be able to identify these differences within the existing data. Data from prophylactic vaccine trials would be much more difficult to model, as breakthrough infections would represent vaccine failure.
| Expanding model of tissue-resident immunity beyond CD8+ T cells
There are several features of the tissue-resident immune response that are likely to be vital for pathogen containment but are not currently amenable to modeling in human infection. In particular, the role of CD4+ T-cell help, direct CD4+ antiviral activity, and broader immunosurveillance remains to be determined, though there is clear evidence that these cells can exert potent antiviral effects. 83, 115 Similarly, it is unknown whether local antigen-presenting cells are dispensable for achieving early elimination of virally infected cells.
As murine knock-out and transgenic systems develop to allow specific focus on the role of each of these subsets, we anticipate constructing accompanying models to capture the intricacies of tri- 
| CON CLUS IONS
Viral dynamics are central to understanding HSV-2 intra-host dynamics, and mathematical models are a necessary tool to interrogate these dynamics. We have developed accurate simulations that describe the leaky nature of ganglionic latency and the vital role of mucosal T RM in early recognition and containment of infection after HSV-2 reactivation. These models have progressed and now can accurately simulate modern clinical trials of HSV-2 antiviral agents. Future work should address the activity of T RM density within specific infection microenvironments, identify the modes of action of therapeutic vaccines, and establish the role of viral evolution in propagating infection.
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